Most providers require at least three weeks at each dose before increasing, but some flexibility exists based on individual tolerance
Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)
Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease
Griebeler ML, Butsch WS, Rodriguez P, Lomeli L, Kampert M, Makin V, et al
Early gastrointestinal symptoms appear in about 40% of users but remain mild
Studies show that glutathione can raise liver protein and bilirubin levels, which may improve liver function